[ Price : $8.95]
The Sedgwick 2022 recall report says both drug and medical device recall events surged higher in 2022, with drugs outpacing device...[ Price : $8.95]
FDA releases the form FDA-483 with eight observations from an inspection at the Madhya, Pradesh, India-based Cipla facility that m...[ Price : $8.95]
A Reuters investigative report relying on anonymous sources says FDA has rejected an application from Elon Musks Neuralink to open...[ Price : $8.95]
A Senate bipartisan bill aims to close a loophole that pharmaceutical companies can exploit to block drug competition, including g...[ Price : $8.95]
FDA commissioner Robert Califf, CBER director Peter Marks, and Childrens Hospital of Philadelphia vaccine expert Paul Offit debate...[ Price : $8.95]
The CDER Office of Generic Drugs annual report says it approved 914 new ANDAs in 2022 and took many other steps under the GDUFA 3 ...[ Price : $8.95]
FDA publishes the International Council on Harmonization Q13 guidance on continuous manufacturing of drug substances and products.[ Price : $8.95]
FDA outlines new potential GMP issues under policy consideration in a discussion paper entitled Artificial Intelligence (AI) in Dr...